Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC

Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC

Butuo Li,1,2,* Cheng Li,3,* Meiying Guo,2,4 Shuheng Shang,2,4 Xiaogang Li,5 Peng Xie,2 Xindong Sun,2 Jinming Yu,1,2 Linlin Wang2 1Department of Radiation Oncology and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Tianjin, People’s Republic of China; 2Departm...

Full description

Bibliographic Details
Main Authors: Li B, Li C, Guo M, Shang S, Li X, Xie P, Sun X, Yu J, Wang L
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:OncoTargets and Therapy
Subjects:
lactate dehydrogenase
bevacizumab
non-small-cell lung cancer
mixed effect model
predictive factor
Online Access:https://www.dovepress.com/predictive-value-of-ldh-kinetics-in-bevacizumab-treatment-and-survival-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/predictive-value-of-ldh-kinetics-in-bevacizumab-treatment-and-survival-peer-reviewed-article-OTT

Similar Items